<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The efficacy of endoscopic screening for <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> symptoms of heartburn and regurgitation in adult subjects depends on the sensitivity of this strategy for detecting <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> in subjects before the development of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus or cardia </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the current study was to determine what proportion of patients with <z:e sem="disease" ids="C0546837,C0152018" disease_type="Neoplastic Process" abbrv="">cancer of the esophagus</z:e> or cardia would have been candidates for a screening endoscopy before their <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis based on the presence and duration of preceding reflux symptoms </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: <z:hpo ids='HP_0000001'>All</z:hpo> patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the cardia, or long-segment <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> presenting for endoscopy at 4 tertiary care and 2 Veterans Affairs (VA) hospitals were given a previously validated questionnaire to determine their recall of common <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> symptoms </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The study population of 375 subjects consisted primarily of 294 (78%) white men </plain></SENT>
<SENT sid="4" pm="."><plain>Only 67 of 110 patients (61%) with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus and 8 of 21 patients (38%) with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the cardia recalled symptoms of heartburn or regurgitation being present for &gt;5 years before their diagnosis of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Only 40 of 110 patients (36%) with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus and 5 of 21 patients (24%) with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the cardia recalled weekly symptoms being present for &gt;5 years before their <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis </plain></SENT>
<SENT sid="6" pm="."><plain>Of the 244 patients with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>, 170 (70%) recalled heartburn or regurgitation for &gt;5 years and 89 patients (37%) recalled weekly symptoms for &gt;5 years </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Current practice, which uses a screening strategy of performing endoscopy in patients with &gt;5 years of heartburn or regurgitation, can detect <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e> in only a limited proportion of those patients at risk for developing <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the cardia </plain></SENT>
</text></document>